The role of exosomal microRNAs in central nervous system diseases

被引:0
|
作者
Yifei Yu
Kun Hou
Tong Ji
Xishu Wang
Yining Liu
Yangyang Zheng
Jinying Xu
Yi Hou
Guangfan Chi
机构
[1] Jilin University,The Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences
[2] The First Hospital of Jilin University,Department of Neurosurgery
[3] Jilin University,Clinical Medical College
[4] School of Pharmaceutical Science of Jilin University,Department of Regeneration Medicine
来源
关键词
Exosome; MicroRNA; Central nervous system; Intercellular communication; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
MicroRNAs (miRNA), endogenous non-coding RNAs approximately 22 nucleotides long, regulate gene expression by mediating translational inhibition or mRNA degradation. Exosomes are a tool for intercellular transmission of information in which miRNA exchange plays an important role. Under pathophysiological conditions in the central nervous system (CNS), cellular transmission of exosomal miRNAs can regulate signaling pathways. Exosomal miRNAs are involved in the occurrence and development of diverse CNS diseases, such as traumatic brain injury, spinal cord injury, stroke, neurodegenerative diseases, epilepsy, and glioma. The use of exosomes as transport vehicles for certain miRNAs provides a novel therapeutic strategy for CNS diseases. Furthermore, the exosomes in body fluids change with the occurrence of diseases, indicating that subtle changes in physiological and pathological processes in vivo could be recognized by analyzing exosomes. Exosomal analysis is expected to act as a novel tool for diagnosis and prediction of neurological diseases. In this review, we present the current understanding of the implications of miRNAs in CNS diseases and summarize the role and mechanism of action of exosomal miRNA in nervous system disease models.
引用
收藏
页码:2111 / 2124
页数:13
相关论文
共 50 条
  • [41] The Role of IRE1 Signaling in the Central Nervous System Diseases
    Ni, Haibo
    Rui, Qin
    Li, Di
    Gao, Rong
    Chen, Gang
    CURRENT NEUROPHARMACOLOGY, 2018, 16 (09) : 1340 - 1347
  • [42] Role of neurological research in rehabilitation after central nervous system diseases
    Mari, F
    Provinciali, L
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1996, 17 (03): : 255 - 255
  • [43] The Role of Long Noncoding RNAs in Central Nervous System and Neurodegenerative Diseases
    Wei, Chang-Wei
    Luo, Ting
    Zou, Shan-Shan
    Wu, An-Shi
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2018, 12
  • [44] Role of NLRP3 inflammasome in central nervous system diseases
    Zhang, Lu
    Tang, Yufen
    Huang, Peng
    Luo, Senlin
    She, Zhou
    Peng, Hong
    Chen, Yuqiong
    Luo, Jinwen
    Duan, Wangxin
    Xiong, Jie
    Liu, Lingjuan
    Liu, Liqun
    CELL AND BIOSCIENCE, 2024, 14 (01):
  • [45] Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases
    Fan, Yishu
    Chen, Zhuohui
    Zhang, Mengqi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [46] The role of gamma oscillations in central nervous system diseases: Mechanism and treatment
    Guan, Ao
    Wang, Shaoshuang
    Huang, Ailing
    Qiu, Chenyue
    Li, Yansong
    Li, Xuying
    Wang, Jinfei
    Wang, Qiang
    Deng, Bin
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [47] Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases
    Yishu Fan
    Zhuohui Chen
    Mengqi Zhang
    Journal of Translational Medicine, 20
  • [48] The Role of Glia Telomere Dysfunction in the Pathogenesis of Central Nervous System Diseases
    Papageorgakopoulou, Manthia A.
    Bania, Angelina
    Lagogianni, Ioanna-Aglaia
    Birmpas, Kyriakos
    Assimakopoulou, Martha
    MOLECULAR NEUROBIOLOGY, 2024, 61 (08) : 5868 - 5881
  • [49] Mechanisms of Modulation of Ferroptosis and Its Role in Central Nervous System Diseases
    Tan, Qingyun
    Fang, Yuying
    Gu, Qiong
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] Role of Grina/Nmdara1 in the Central Nervous System Diseases
    Chen, Kai
    Yang, Liu Nan
    Lai, Chuan
    Liu, Dan
    Zhu, Ling-Qiang
    CURRENT NEUROPHARMACOLOGY, 2020, 18 (09) : 861 - 867